Newcastle United are emerging as the frontrunners to sign AZ Alkmaar midfielder Kees Smit ahead of several Premier League rivals this summer.
Multiple top-flight clubs have begun seriously scouting the Dutch youngster, with a formal approach expected once the transfer window opens.
Smit has developed into one of the most exciting midfield prospects in the Eredivisie over the past couple of seasons, drawing widespread attention across Europe.
Newcastle are believed to be at the head of the queue, according to TeamTalk, as the Magpies prepare for potential departures in the middle of the park.
The club see Smit as a viable replacement for a player of the calibre of Sandro Tonali, should the Italian depart St James’ Park this summer.
While Newcastle’s interest is strong, they are not alone, with Chelsea, Liverpool, Brighton, Crystal Palace, and Fulham all said to be monitoring the situation closely.
However, Smit’s personal ambitions may give Newcastle and the other mid-table clubs a significant edge over the bigger names in this race.
The midfielder is reportedly determined to join a club where he is guaranteed regular first-team minutes, making the prospect of competing for a starting spot at Liverpool or Chelsea less appealing.
A further motivation behind his desire to move is his omission from the Netherlands World Cup squad, a major disappointment that has seemingly strengthened his resolve to take the next step in his development.
Clubs known for nurturing young talent across Europe are also monitoring Smit, meaning Premier League sides will face competition from the continent as well.
Newcastle’s ability to offer consistent playing time at a high level could prove to be the decisive factor in winning the race for the AZ Alkmaar star.
With European interest growing and domestic clubs circling, Smit looks certain to be one of the more talked-about transfer targets as the summer window approaches.
The post Newcastle United Hold Key Advantage Over Chelsea And Liverpool In Race For Kees Smit appeared first on Gooner Daily.